SC 13G Filing

Company

Esperion Therapeutics, Inc.

Filed

August 21, 2017

Accession Number

0001382333-17-000004

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →